alendronate has been researched along with Paraneoplastic Syndromes in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Paraneoplastic Syndromes: In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Followed by hydration with saline, pamidronate is effective for the control of symptomatic hypercalcemia." | 4.79 | [Paraneoplastic syndrome]. ( Hara, N; Nakanishi, Y; Takayama, K, 1997) |
| "Malignant melanoma has previously been reported with paraneoplastic syndromes including dermatomyositis." | 1.37 | Metastatic malignant melanoma and dermatomyositis: A paraneoplastic phenomenon. ( Tu, J; Von Nida, J, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tu, J | 1 |
| Von Nida, J | 1 |
| Nakanishi, Y | 1 |
| Takayama, K | 1 |
| Hara, N | 1 |
1 review available for alendronate and Paraneoplastic Syndromes
| Article | Year |
|---|---|
[Paraneoplastic syndrome].
Topics: Alendronate; Anticoagulants; Cushing Syndrome; Diagnosis, Differential; Diphosphonates; Disseminated | 1997 |
1 other study available for alendronate and Paraneoplastic Syndromes
| Article | Year |
|---|---|
Metastatic malignant melanoma and dermatomyositis: A paraneoplastic phenomenon.
Topics: Adult; Alendronate; Antibodies, Antinuclear; Calcium; Dermatologic Agents; Dermatomyositis; Drug The | 2011 |